We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

Deconstructing the Psychosis Risk Syndrome Moving the Field of Prevention Forward

Barbara A. Cornblatt, PhD, MBA1,2,3,4; Ricardo E. Carrión, PhD1,2,3
[+] Author Affiliations
1Division of Psychiatry Research, The Zucker Hillside Hospital, North Shore–Long Island Jewish Health System, Glen Oaks, New York
2Center for Psychiatric Neuroscience, The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System, Manhasset, New York
3Department of Psychiatry, Hofstra North Shore–Long Island Jewish School of Medicine, Hempstead, New York
4Department of Molecular Medicine, Hofstra North Shore–Long Island Jewish School of Medicine, Hempstead, New York
JAMA Psychiatry. 2016;73(2):105-106. doi:10.1001/jamapsychiatry.2015.2454.
Text Size: A A A
Published online


The movement toward prevention of psychosis was launched in the mid-1990s1 with the introduction of a set of criteria for identifying individuals at risk for future illness. Referred to as the prodromal phase of illness, it was theorized that by identifying youngsters (primarily adolescents and young adults) several years before onset, preemptive intervention could block the emergence of florid psychosis. Three subgroups were included in the definition of clinical high risk (CHR), also called ultrahigh risk (UHR), based to a large extent on the clinical observation: (1) presence of attenuated positive symptoms (APS) considered an early, subtle form of the hallmark symptoms of psychosis; (2) presence of positive symptoms at full psychotic intensity for brief, limited time points, referred to as brief intermittent psychotic symptoms (BIPS) or brief limited intermittent psychotic episode (BLIPS); and (3) a trait/state combination of genetic risk or schizotypal personality disorder accompanied by functional decline, labeled genetic risk and decline (GRD). These 3 subgroups have remained relatively unchanged since their introduction, and their criteria have dominated prodromal research.2 They are typically merged into a single CHR research entity, with no distinction made and with no understanding of the extent to which variability in conversion rates across studies is due to differences in subgroup composition. Furthermore, the CHR research entity is based on the implicit assumption that the 3 subgroups are comparable although there is no evidence available to indicate that APS, BIPS, and GRD represent similar progressions of the disease, and, in fact, they appear to be quite separate and (sometimes very) different risk syndromes.

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
A Brief Word About Quality

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Reliability of the MAST, CAGE, and AUDIT Questionnaires